Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Evaxion Biotech
(NASDAQ:EVAX)
Intraday
$4.10
-0.09
[-2.15%]
After-Hours
$4.10
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$4.10
-0.09
[-2.15%]
At close: Apr 22
$4.10
0
[0.00%]
PreMarket: 4:10PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Evaxion Biotech Stock (NASDAQ:EVAX)
Evaxion Biotech Stock (NASDAQ: EVAX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 17, 2024
Evaxion Announces First Patient Completed Dosing With Personalized Cancer Vaccine EVX-01
Benzinga Newsdesk
-
5 days ago
Wednesday, April 03, 2024
HC Wainwright & Co. Reiterates Buy on Evaxion Biotech, Maintains $14 Price Target
Benzinga Newsdesk
-
Apr 3, 2024, 6:41AM
Tuesday, April 02, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Apr 2, 2024, 12:31PM
Ladenburg Thalmann Upgrades Evaxion Biotech to Buy, Announces $8 Price Target
Benzinga Newsdesk
-
Apr 2, 2024, 11:39AM
Evaxion Biotech Concludes Large Non-rodent Animal Infection Studies, Testing Antigens From Evaxion's Preclinical EVX-b1 Vaccine Candidate Against Staphylococcus Aureus, Studies Showed EVX-b1 Antigens Significantly Reduced Disease Burden
Benzinga Newsdesk
-
Apr 2, 2024, 7:08AM
Wednesday, March 27, 2024
Recap: Evaxion Biotech Q4 Earnings
Benzinga Insights
-
Mar 27, 2024, 9:35AM
Evaxion's 2023 Cash And Cash Equivalents Of $5.6M And Capital Raise Of $12.7M Is Expected To Provide Cash Runway Into April 2025
Benzinga Newsdesk
-
Mar 27, 2024, 7:36AM
Evaxion Biotech Q4 EPS $(0.16) Beats $(1.60) Estimate, Sales $73.00K
Benzinga Newsdesk
-
Mar 27, 2024, 7:34AM
Wednesday, March 20, 2024
HC Wainwright & Co. Reiterates Buy on Evaxion Biotech, Maintains $14 Price Target
Benzinga Newsdesk
-
Mar 20, 2024, 6:54AM
Tuesday, February 20, 2024
Evaxion Announces Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD (Tradename of Merck & Co., Inc., Rahway, NJ, USA)
Benzinga Newsdesk
-
Feb 20, 2024, 7:32AM
Monday, February 12, 2024
HC Wainwright & Co. Initiates Coverage On Evaxion Biotech with Buy Rating, Announces Price Target of $14
Benzinga Newsdesk
-
Feb 12, 2024, 7:51AM
Wednesday, February 07, 2024
Evaxion Regains Compliance With Nasdaq Minimum Bid Price Requirement
Benzinga Newsdesk
-
Feb 7, 2024, 8:34AM
Thursday, February 01, 2024
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Feb 1, 2024, 1:17PM
Evaxion Biotech shares are trading lower after the company announced the pricing of a $15 million public offering of 3.750 million ADS at $4.00 per ADS.
Benzinga Newsdesk
-
Feb 1, 2024, 12:37PM
Evaxion Biotech Announces Pricing Of $15M Public Offering Of 3.750M ADS At $4.00/ADS
Benzinga Newsdesk
-
Feb 1, 2024, 9:21AM
Wednesday, January 31, 2024
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 31, 2024, 1:18PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jan 31, 2024, 12:31PM
Friday, January 26, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Jan 26, 2024, 12:31PM
Thursday, January 25, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Jan 25, 2024, 8:06AM
Wednesday, January 24, 2024
Dow Edges Lower; US Composite PMI Rises In January
Avi Kapoor
-
Jan 24, 2024, 3:46PM
Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today?
Vandana Singh
-
Jan 24, 2024, 2:08PM
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Jan 24, 2024, 1:05PM
Crude Oil Rises Over 1%; DuPont Shares Plunge
Avi Kapoor
-
Jan 24, 2024, 12:04PM
Evaxion Biotech shares are trading higher after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of December 21, 2023. Also, the company announced an expanded commitment to developing tailored cancer vaccines.
Benzinga Newsdesk
-
Jan 24, 2024, 11:19AM
Evaxion Biotech A/S Shares Halted On Circuit Breaker To The Downside, Stock Now Up 126.1%
Benzinga Newsdesk
-
Jan 24, 2024, 10:15AM
Evaxion Biotech A/S Shares Resume Trade
Benzinga Newsdesk
-
Jan 24, 2024, 9:52AM
Evaxion Biotech Shares Halted On Circuit Breaker To The Upside, Stock Now Up 94.4%
Benzinga Newsdesk
-
Jan 24, 2024, 9:44AM
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales
Avi Kapoor
-
Jan 24, 2024, 9:43AM
Market-Moving News for January 24th
Benzinga Newsdesk
-
Jan 24, 2024, 8:34AM
Evaxion To Develop Tailored Novel Cancer Vaccines
Benzinga Newsdesk
-
Jan 24, 2024, 8:32AM
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 24, 2024, 8:14AM
Tuesday, January 23, 2024
Evaxion Biotech shares are trading higher after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of December 21, 2023.
Benzinga Newsdesk
-
Jan 23, 2024, 4:44PM
Evaxion Biotech A/S 13G Filing Shows Merck & Co., Inc. Reported A 11.4% Stake In The Company As Of December 21, 2023
Benzinga Newsdesk
-
Jan 23, 2024, 3:35PM
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 23, 2024, 2:37PM
Monday, January 22, 2024
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Benzinga Newsdesk
-
Jan 22, 2024, 8:55AM
Friday, January 19, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk
-
Jan 19, 2024, 7:50PM
Tuesday, January 16, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 16, 2024, 8:05AM
Monday, January 08, 2024
Evaxion Announces Plan To Implement 1-To-10 ADS Ratio Change Effective Jan. 22
Benzinga Newsdesk
-
Jan 8, 2024, 8:42AM
Thursday, December 21, 2023
Ladenburg Thalmann Downgrades Evaxion Biotech to Neutral
Benzinga Newsdesk
-
Dec 21, 2023, 7:10AM
Tuesday, December 19, 2023
Evaxion Biotech: Q3 Earnings Insights
Benzinga Insights
-
Dec 19, 2023, 4:20PM
Evaxion Biotech Q3 EPS $(0.21) Misses $(0.19) Estimate
Benzinga Newsdesk
-
Dec 19, 2023, 4:17PM
Evaxion Biotech Announces $5.3M Private Placement Financing
Benzinga Newsdesk
-
Dec 19, 2023, 9:28AM
Tuesday, November 28, 2023
Evaxion To Unveil AI-Immunology Precision Cancer Vaccine Concept
Benzinga Newsdesk
-
Nov 28, 2023, 8:28AM
Thursday, November 09, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Nov 9, 2023, 4:31PM
Monday, November 06, 2023
Evaxion Shares Latest EVX-01 Phase 2 Clinical Data In Webinar With Key Opinion Leader Adnan Khattak
Benzinga Newsdesk
-
Nov 6, 2023, 10:13AM
Tuesday, October 31, 2023
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Oct 31, 2023, 1:36PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Oct 31, 2023, 1:31PM
Evaxion Announces Initial Phase 2 Clinical Data On Its Personalized Cancer Vaccine EVX-01
Benzinga Newsdesk
-
Oct 31, 2023, 11:17AM
Thursday, October 26, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Oct 26, 2023, 9:06AM
New Clinical Data On Evaxion's AI-Immunology-Based Personalized Cancer Vaccines To Be Presented
Benzinga Newsdesk
-
Oct 26, 2023, 8:38AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch